News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
709,782 Results
Type
Article (69381)
Company Profile (406)
Press Release (639995)
Multimedia
Podcasts (110)
Webinars (13)
Section
Business (182858)
Career Advice (3299)
Deals (32896)
Drug Delivery (114)
Drug Development (83401)
Employer Resources (183)
FDA (15940)
Job Trends (14663)
News (322478)
Policy (31667)
Tag
Academia (2972)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (93)
Alliances (47297)
ALS (103)
Alzheimer's disease (1483)
Antibody-drug conjugate (ADC) (152)
Approvals (15906)
Artificial intelligence (292)
Autoimmune disease (30)
Automation (16)
Bankruptcy (321)
Best Places to Work (11888)
BIOSECURE Act (22)
Biosimilars (110)
Biotechnology (310)
Bladder cancer (84)
Brain cancer (31)
Breast cancer (309)
Cancer (2427)
Cardiovascular disease (203)
Career advice (2792)
Career pathing (33)
CAR-T (176)
Cell therapy (495)
Cervical cancer (22)
Clinical research (67220)
Collaboration (911)
Company closure (2)
Compensation (537)
Complete response letters (29)
COVID-19 (2753)
CRISPR (49)
C-suite (264)
Cystic fibrosis (109)
Data (2352)
Decentralized trials (2)
Denatured (31)
Depression (54)
Diabetes (289)
Diagnostics (6394)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (46)
Drug discovery (133)
Drug pricing (118)
Drug shortages (31)
Duchenne muscular dystrophy (104)
Earnings (69508)
Editorial (47)
Employer branding (23)
Employer resources (159)
Events (124404)
Executive appointments (754)
FDA (17343)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (804)
Gene editing (123)
Generative AI (26)
Gene therapy (364)
GLP-1 (798)
Government (4762)
Grass and pollen (6)
Guidances (148)
Healthcare (19691)
Huntington's disease (25)
IgA nephropathy (30)
Immunology and inflammation (147)
Indications (30)
Infectious disease (2900)
Inflammatory bowel disease (157)
Inflation Reduction Act (11)
Influenza (51)
Intellectual property (98)
Interviews (631)
IPO (16185)
IRA (47)
Job creations (3228)
Job search strategy (2290)
Kidney cancer (10)
Labor market (41)
Layoffs (488)
Leadership (23)
Legal (7128)
Liver cancer (77)
Lung cancer (338)
Lymphoma (158)
Machine learning (9)
Management (62)
Manufacturing (342)
MASH (78)
Medical device (13456)
Medtech (13460)
Mergers & acquisitions (17317)
Metabolic disorders (767)
Multiple sclerosis (86)
NASH (21)
Neurodegenerative disease (112)
Neuropsychiatric disorders (34)
Neuroscience (2085)
NextGen: Class of 2025 (7010)
Non-profit (4782)
Now hiring (32)
Obesity (408)
Opinion (264)
Ovarian cancer (82)
Pain (103)
Pancreatic cancer (85)
Parkinson's disease (158)
Partnered (21)
Patents (243)
Patient recruitment (117)
Peanut (49)
People (55325)
Pharmaceutical (79)
Pharmacy benefit managers (21)
Phase I (21034)
Phase II (29594)
Phase III (21965)
Pipeline (1375)
Policy (171)
Postmarket research (2769)
Preclinical (9477)
Press Release (70)
Prostate cancer (113)
Psychedelics (38)
Radiopharmaceuticals (267)
Rare diseases (432)
Real estate (5619)
Recruiting (73)
Regulatory (22050)
Reports (41)
Research institute (2600)
Resumes & cover letters (528)
Rett syndrome (5)
RNA editing (5)
RSV (44)
Schizophrenia (80)
Series A (139)
Series B (91)
Service/supplier (10)
Sickle cell disease (59)
Special edition (20)
Spinal muscular atrophy (166)
Sponsored (33)
Startups (3558)
State (2)
Stomach cancer (16)
Supply chain (68)
Tariffs (47)
The Weekly (77)
Vaccines (735)
Venture capitalists (44)
Weight loss (283)
Women's health (35)
Worklife (20)
Date
Last 7 days (947)
Last 30 days (3007)
Last 365 days (33438)
2025 (12078)
2024 (36401)
2023 (41130)
2022 (52125)
2021 (56903)
2020 (55200)
2019 (48601)
2018 (36588)
2017 (33243)
2016 (33252)
2015 (38509)
2014 (31319)
2013 (27300)
2012 (28980)
2011 (29145)
2010 (27412)
Location
Africa (968)
Alabama (57)
Alaska (7)
Arizona (192)
Arkansas (14)
Asia (41344)
Australia (7549)
California (6399)
Canada (2048)
China (555)
Colorado (271)
Connecticut (288)
Delaware (154)
Europe (96991)
Florida (930)
Georgia (216)
Idaho (54)
Illinois (592)
India (26)
Indiana (309)
Iowa (11)
Japan (171)
Kansas (109)
Kentucky (26)
Louisiana (12)
Maine (68)
Maryland (949)
Massachusetts (4943)
Michigan (222)
Minnesota (405)
Mississippi (1)
Missouri (86)
Montana (28)
Nebraska (22)
Nevada (63)
New Hampshire (61)
New Jersey (1798)
New Mexico (30)
New York (1826)
North Carolina (1053)
North Dakota (8)
Northern California (2793)
Ohio (215)
Oklahoma (15)
Oregon (35)
Pennsylvania (1414)
Puerto Rico (12)
Rhode Island (32)
South America (1286)
South Carolina (23)
Southern California (2402)
Tennessee (94)
Texas (932)
United States (24254)
Utah (183)
Virginia (160)
Washington D.C. (67)
Washington State (590)
West Virginia (3)
Wisconsin (53)
709,782 Results for "the wyss institute at harvard university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
The Colossal Foundation Donates $1.5M to the Wyss Institute at Harvard University to Advance Artificial Womb Technology for Wildlife Conservation
January 13, 2025
·
5 min read
Press Releases
Florey Biosciences spins out of Harvard Wyss Institute to develop a medical food aimed at managing impacts of antibiotic use
October 1, 2024
·
1 min read
Press Releases
Vizgen Announces End of Litigation with 10x Genomics and Harvard University
April 3, 2025
·
2 min read
ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University
Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.
March 11, 2024
·
3 min read
Press Releases
Wyss Center Partners with BrainScape Medical to License Groundbreaking Epios® Technology
February 6, 2025
·
2 min read
Business
Dandelion Science and the Wyss Center Geneva announce AI partnership to generate non-invasive brain therapies
The Wyss Center for Bio and Neuroengineering in Geneva and Dandelion Science are excited to announce a partnership focused on a cutting-edge generative AI neuromodulation platform that could speed the development of safe, non-invasive ways of treating neurodegenerative and neuropsychiatric disorders.
June 11, 2024
·
3 min read
Press Releases
Harvard Bioscience Announces CFO Transition
April 11, 2025
·
3 min read
Press Releases
Wyss Center for Bio and Neuroengineering Announces Venture with dEEGtal Insight: An Innovative Tool for Early Epilepsy Detection
December 10, 2024
·
2 min read
Press Releases
Roche announces launch of Roche Genentech Innovation Center Boston based at Harvard’s Enterprise Research Campus in Allston
March 7, 2025
·
6 min read
Pharm Country
The Wyss Foundation Provides $5 Million in Funding for Children’s Hospital of Philadelphia’s Wyss/Campbell Center for Thoracic Insufficiency Syndrome
Children’s Hospital of Philadelphia is thrilled to announce a gift of $5 million from the Wyss Foundation to support innovations that improve the lives of patients with thoracic insufficiency syndrome.
February 22, 2024
·
4 min read
1 of 70,979
Next
